Systemic Lupus Erythematosus [clinicaltrials_resource:41337c278bf8e25abac58b5b884e1dde]
Prevention of Arthritis-Related Work Disability [clinicaltrials:NCT00000416]Psychoeducational Approach to Improve Health in Lupus [clinicaltrials:NCT00000417]Safety of Estrogens in Lupus: Hormone Replacement Therapy [clinicaltrials:NCT00000419]Safety of Estrogens in Lupus: Birth Control Pills [clinicaltrials:NCT00000420]clinicaltrials:NCT00000421Drug Therapy in Lupus Nephropathy [clinicaltrials:NCT00001212]Study of Systemic Lupus Erythematosus [clinicaltrials:NCT00001372]Cyclophosphamide and Fludarabine to Treat Lupus Nephritis [clinicaltrials:NCT00001676]Ultraviolet Light Therapy for Systemic Lupus Erythematosus [clinicaltrials:NCT00004375]Phase III Randomized, Double-Blind, Placebo-Controlled Study of Dehydroepiandrosterone in Women With Active Systemic Lupus Erythematosus [clinicaltrials:NCT00004662]Epidemiologic Study of Reproductive Outcome in Women With Systemic Lupus Erythematosus [clinicaltrials:NCT00004663]Phase II Study of Long-Term Dehydroepiandrosterone for Systemic Lupus Erythematosus [clinicaltrials:NCT00004665]Study of Individualized Instruction Versus Pamphlet in Systemic Lupus Erythematosus [clinicaltrials:NCT00004756]Phase II/III Randomized, Double-Blind, Placebo-Controlled Study of Dehydroepiandrosterone in Women With Mild to Moderate Systemic Lupus Erythematosus [clinicaltrials:NCT00004795]Autologous Peripheral Blood Stem Cell Transplantation in Patients With Life Threatening Autoimmune Diseases [clinicaltrials:NCT00006055]Randomized Study of Oral Contraceptives or Hormone Replacement Therapy in Women With Systemic Lupus Erythematosus [clinicaltrials:NCT00006133]Study of the Predictors of the Course and Early Outcome of Patients With Systemic Lupus Erythematosus: Nature Versus Nurture [clinicaltrials:NCT00006134]clinicaltrials:NCT00010335Pilot Study of Cyclophosphamide in Patients With Life-Threatening Systemic Lupus Erythematosus or Antiphospholipid Antibody Syndrome [clinicaltrials:NCT00010400]Humanized LL2IGG to Treat Systemic Lupus Erythematosus [clinicaltrials:NCT00011908]Phase I Study of Immune Ablation and CD34+ Peripheral Blood Stem Cell Support in Patients With Systemic Lupus Erythematosus [clinicaltrials:NCT00017641]Safety and Efficacy Study of LJP 394 (Abetimus Sodium) to Treat Lupus Kidney Disease [clinicaltrials:NCT00035308]Study of GL701 in Men With Systemic Lupus Erythematosus [clinicaltrials:NCT00037128]Role of Antibodies in Cognitive Dysfunction in Patients With Systemic Lupus Erythematosus [clinicaltrials:NCT00042523]clinicaltrials:NCT00046774Prevention of Atherosclerosis and Heart Disease in Patients With Systemic Lupus Erythematosis (SLE) [clinicaltrials:NCT00054938]Study of Families With Twins or Siblings Discordant for Rheumatic Disorders [clinicaltrials:NCT00055055]Health Beliefs and Health Behaviors Among Minorities With Rheumatic Diseases [clinicaltrials:NCT00069342]clinicaltrials:NCT00071175clinicaltrials:NCT00074373GL701 (Prestara™) in Women With Systemic Lupus Erythematosus Receiving Treatment With Glucocorticoids [clinicaltrials:NCT00082511]Study of Epratuzumab in Systemic Lupus Erythematosus [clinicaltrials:NCT00111306]clinicaltrials:NCT00119678Lupus Atherosclerosis Prevention Study [clinicaltrials:NCT00120887]clinicaltrials:NCT00124514Skin Denervation in Systemic Lupus Erythematosus [clinicaltrials:NCT00155532]Decoy Receptor 3 (DcR3) Polymorphisms in Rheumatoid Arthritis (RA) and Systemic Lupus Erythematosus (SLE) [clinicaltrials:NCT00172666]Memantine in Systemic Lupus Erythematosus [clinicaltrials:NCT00181298]Study of Endothelial Dysfunction in Systemic Lupus and Its Role in Heart Disease [clinicaltrials:NCT00188188]HIPP Learning to Live Better With Lupus: The Health Improvement and Prevention Program in Systemic Lupus Erythematosus [clinicaltrials:NCT00188357]
condition [clinicaltrials_vocabulary:condition]
exclusion criteria [clinicaltrials_vocabulary:exclusion-criteria]
inclusion criteria [clinicaltrials_vocabulary:inclusion-criteria]
Systemic Lupus Erythematosus [clinicaltrials_resource:41337c278bf8e25abac58b5b884e1dde]
Bio2RDF identifier
41337c278bf8e25abac58b5b884e1dde
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:41337c278bf8e25abac58b5b884e1dde
identifier
clinicaltrials_resource:41337c278bf8e25abac58b5b884e1dde
title
Systemic Lupus Erythematosus
@en
label
Systemic Lupus Erythematosus [clinicaltrials_resource:41337c278bf8e25abac58b5b884e1dde]
@en